Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion type Assertion NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_head.
- NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion description "[Treatment of cystic fibrosis by gene therapy will require the development of vectors capable of efficient and safe transfer of a functional cystic fibrosis transmembrane conductance regulator (CFTR) cDNA to airway epithelia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_provenance.
- NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion evidence source_evidence_literature NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_provenance.
- NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion SIO_000772 7548271 NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_provenance.
- NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion wasDerivedFrom befree-2016 NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_provenance.
- NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_assertion wasGeneratedBy ECO_0000203 NP1312103.RArEbC6X5HY_-VfggB2uPZTDsZm3Zj2uW1WKfERHDlYFA130_provenance.